Considering this, breast cancer can be grouped as hormone receptor-positive (ER+ and/or PR+), HER-2 enriched (HER2+) when there is overexpression/amplification of this gene, or triple negative, which is deficient in the expression of all markers (ER−, PR−, HER2−) [9]. The gene discussed is NR4A1; the disease is breast carcinoma.